T‐cell acute lymphoblastic leukaemia: recent molecular biology findings
- 7 December 2011
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 156 (3) , 303-315
Abstract
Summary: For many years, T‐cell acute lymphoblastic leukaemia (T‐ALL) has been considered and treated as a single malignancy, but divergent outcomes in T‐ALL patients receiving uniform treatment protocols encouraged intensive research on the molecular biology of this disease. Recent findings in the field demonstrate that T‐ALL is much more heterogeneous than originally believed and extremely diverse outcomes of patients require refinement of T‐ALL classification, leading to subtype‐specific adjustment of treatment. Many different biological features of T‐ALL blast cells have recently been found to contribute to disease development and patient outcome and their analysis could potentially be introduced into improved diagnostics and classification of the disease. This review focuses on five key issues of T‐ALL biology: chromosome aberrations, gene expression profiles, gene mutations, DNA methylation patterns, and immunoglobulin/T cell receptor (Ig/TCR) gene rearrangements. Additionally, molecular monitoring of minimal residual disease, by far the most reliable independent prognostic factor in T‐ALL, has been highlighted in the context of Ig/TCR gene rearrangements. Translation of this biological information into better prognostic classification and more effective treatment should lead to improvement of outcome in T‐ALL patients.Keywords
This publication has 90 references indexed in Scilit:
- The TLX1 oncogene drives aneuploidy in T cell transformationNature Medicine, 2010
- The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of functionLeukemia, 2010
- Bcl11b represses a mature T‐cell gene expression program in immature CD4+CD8+ thymocytesEuropean Journal of Immunology, 2010
- Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemiaNature Genetics, 2010
- PHF6 mutations in T-cell acute lymphoblastic leukemiaNature Genetics, 2010
- The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupLeukemia, 2009
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experienceArchivum Immunologiae et Therapiae Experimentalis, 2008
- PHD fingers in human diseases: Disorders arising from misinterpreting epigenetic marksMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008